Truvian
PrivateLast Round
VC Round
Jul 17, 2024
Total Funding Raised
$176.3M
Company Overview
Truvian is a healthcare technology company that develops an automated benchtop blood testing platform designed to provide lab-accurate diagnostic results in decentralized care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truvian Comparables
Compare Truvian with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vital | 92% | |
| Genalyte | 85% | |
| Osler Diagnostics | 85% | |
Truvian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 17, 2024 | ||||
| Debt | Sep 14, 2021 | ||||
| Series C | Feb 24, 2021 | ||||
| Series B | Nov 20, 2019 | ||||
| Series A | Sep 1, 2017 |
Key People
Founding team and executive leadership
Truvian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series C, VC Round, Series B |
| Wasson Enterprise | Series C |
| Pacific West Bank | Debt |
| Domain Associates | Series B, Series A |
| GreatPoint Ventures | Series C, Series B |
| Medical Excellence Capital | VC Round |
| General Catalyst | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Proprietary blood testing platform is currently under FDA review.
- Jan 13, 2025
Developing a comprehensive benchtop solution for blood testing.
Truvian Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Truvian's valuation, stock price, and market status.